Chambers J T
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.
Yale J Biol Med. 1989 Jul-Aug;62(4):351-65.
Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in addition to surgery is needed, and conservation of ovarian tissue for future childbearing may be appropriate. In advanced stages, the use of adjuvant therapy has not consistently led to cures, and complications have been reported. A randomized study of no adjuvant therapy versus adjuvant treatment with long-term follow-up will be necessary to determine the efficacy of additional treatment.
交界性卵巢肿瘤预后良好。对于Ⅰ期疾病，除手术外无需其他治疗，保留卵巢组织以备未来生育可能是合适的。在晚期，辅助治疗的使用并未一直带来治愈效果，且有并发症的报道。有必要进行一项关于不进行辅助治疗与进行辅助治疗并长期随访的随机研究，以确定额外治疗的疗效。
